Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types

Paclitaxel, the most commonly used form of chemotherapy, is utilized in curative protocols in different types of cancer. The response to treatment differs among patients. Biological interpretation of a mechanism to explain this personalized response is still unavailable. Since paclitaxel is known to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Precis Oncol
Main Authors: Ben-Hamo, Rotem, Zilberberg, Alona, Cohen, Helit, Bahar-Shany, Keren, Wachtel, Chaim, Korach, Jacob, Aviel-Ronen, Sarit, Barshack, Iris, Barash, Danny, Levanon, Keren, Efroni, Sol
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478919/
https://ncbi.nlm.nih.gov/pubmed/31044156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-019-0084-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados